|Loyola University of Chicago Stritch School of Medicine|
|City: Chicago||State: IL|
In general, this school's policy focuses a great deal on disclosure of possible conflicts of interest, as well as supervisory approval for many activities that are likely to pose a conflict of interest. This institution's policy is particularly strong in the area of consulting, as all consulting services must be disclosed, approved by a supervisor, and have a written contract in place. Although on-site meals are banned, gifts are not adequately limited. One major improvement would be the the inclusion of courses on conflict of interest in the medical school curriculum.
This institution did not submit any new or additional policies for the 2012-13 AMSA PharmFree Scorecard.
This institution has not consented to allow the public posting of their policies.
This institution's evaluation was last updated: 12/09/2010
|Gifts & Meals||On-site meals funded by industry are banned, but the policy does not substantially limit gift giving to faculty and staff.|
|Consulting relationships||A very strong policy. Consulting services provided to a specific company must be limited; compensation must not exceed fair market value; and all services provided must be disclosed, approved by a supervisor, and subject to a written contract.|
|Industry-funded speaking relationships||Industry personnel are prohibited from writing or directing the content of speeches given by AMC personnel in Speaker's Bureaus. All speaking arrangements require prior approval and a written contract.|
|Disclosure||All faculty and staff are required to disclose all financial ties with private industry on an annual basis.|
|Pharmaceutical samples||A newer policy states that Industry representatives are prohibited from distributing pharmaceutical samples anywhere on campus. Care should be taken to update older policies to conform with this rule to avoid confusion.|
|Purchasing & Formularies||Key personnel, including those making formulary decisions, must have their annual disclosures personally reviewed by the chief compliance officer. Further, any physician requesting that a new drug be added to the formulary must declare any potential conflicts of interest along with their request.|
|Industry Sales Representatives||Industry sales representatives are allowed in the medical center by appointment only. They are allowed in some specified patient care areas only for "bona fide" reasons.|
|On-campus Education||All income and activity expenses are managed from the Division of CME finanacial account. Funds for educational events must be used independent of industry influence.|
|Attendance at Industry-Sponsored Lectures & Meetings Off-Campus||The occasional acceptance of entertainment and meals, though modest, from vendors at off-site events does not provide a substantial limit on gifting for attending such events. It is difficult to quantify 'on an occasional basis' as such decision making is very discretionary.|
|Industry Support for Scholarships & Funds for Trainees||Industry funding of scholarships must be "coordinated with the Office of Development", but no oversight is specified and there are no other significant limits evident on the ability of industry to choose recipients.|
|Medical school curriculum||No policy, or policy not provided.|
|Do the policies specify an oversight mechanism?||This policy establishes oversight.|
|Are there explicit sanctions for noncompliance?||This policy establishes sanctions.|
|Good progress toward model policy|
|No policy, or policy unlikely to have a substantial effect on behavior|
|Did not report|
|Policy not relevant to this institution (e.g., does not make purchasing decisions)|